memo - Magazine of European Medical Oncology 2/2016

Mathilde Foedermayr, Miriam Sebesta, Margaretha Rudas, Anna S. Berghoff, Regina Promberger, Matthias Preusser, Peter Dubsky, Michael Gnant, Guenther G. Steger, Ansgar Weltermann, Christoph C. Zielinski, Otto Zach, Rupert Bartsch

01.06.2016 | short review | Ausgabe 2/2016 Open Access

CDK4/6 inhibition in luminal breast cancer

Simon Peter Gampenrieder, Gabriel Rinnerthaler, Richard Greil

PDF-Version jetzt herunterladen Zum Volltext

01.06.2016 | short review | Ausgabe 2/2016 Open Access

Immune checkpoint blockade in ovarian cancer

Lukas Weiss MD PhD, Florian Huemer MD, Brigitte Mlineritsch MD, Richard Greil MD

PDF-Version jetzt herunterladen Zum Volltext

01.06.2016 | case report | Ausgabe 2/2016

Endometrial cancer treated with levonorgestrel-releasing intrauterine device for almost three years in an elderly woman with comorbidity

Lisbeth Anita Andreasen M.D., Sofie Leisby Antonsen M.D., Ph.D, Annette Settnes M.D., Ph.D

01.06.2016 | short review | Ausgabe 2/2016

Circulating tumor cells and circulating tumor DNA in colon cancer

Prospects and difficulties in implementation

Mikhail Fedyanin MD, PhD, Elizaveta Polyanskaya MD, Sergei Tjulandin MD, PhD

01.06.2016 | comment | Ausgabe 2/2016

Is there room for chemotherapy in elderly patients with metastatic castration-resistant prostate cancer (mCRPC) in the era of targeted hormone therapy?

Dr. Ercan Müldür

01.06.2016 | review | Ausgabe 2/2016

Initial emergencies in children and adolescents with malignant hematologic–oncological diseases

Andishe Attarbaschi, Georg Mann

memo - Magazine of European Medical Oncology

Ausgabe 2/2016

Inhaltsverzeichnis ( 11 Artikel )

memo—new frontiers to be reached

Intravascular large B‑cell lymphoma

Long-term treatment of hairy cell leukemia with interferon-α: still a viable therapeutic option

Immunotherapy for head and neck squamous cell carcinoma

Association of TP53 mutations with TP53 codon 72 polymorphism and outcome in triple-negative breast cancer

CDK4/6 inhibition in luminal breast cancer

Immune checkpoint blockade in ovarian cancer

Endometrial cancer treated with levonorgestrel-releasing intrauterine device for almost three years in an elderly woman with comorbidity

Circulating tumor cells and circulating tumor DNA in colon cancer

Is there room for chemotherapy in elderly patients with metastatic castration-resistant prostate cancer (mCRPC) in the era of targeted hormone therapy?

Initial emergencies in children and adolescents with malignant hematologic–oncological diseases

Ausgabe 2/2019

Sonderheft 2/2019

Sonderheft 1/2019

Ausgabe 1/2019

Ausgabe 4/2018

Sonderheft 4/2018

Sonderheft 3/2018

Ausgabe 3/2018

Sonderheft 2/2018

Ausgabe 2/2018

Springer Medizin Österreich

Inhaltsverzeichnis ( 11 Artikel )

memo—new frontiers to be reached

Intravascular large B‑cell lymphoma

Long-term treatment of hairy cell leukemia with interferon-α: still a viable therapeutic option

Immunotherapy for head and neck squamous cell carcinoma

Association of TP53 mutations with TP53 codon 72 polymorphism and outcome in triple-negative breast cancer

CDK4/6 inhibition in luminal breast cancer

Immune checkpoint blockade in ovarian cancer

Endometrial cancer treated with levonorgestrel-releasing intrauterine device for almost three years in an elderly woman with comorbidity

Circulating tumor cells and circulating tumor DNA in colon cancer

Is there room for chemotherapy in elderly patients with metastatic castration-resistant prostate cancer (mCRPC) in the era of targeted hormone therapy?

Initial emergencies in children and adolescents with malignant hematologic–oncological diseases

Aktuelle Ausgaben

Ausgabe 2/2019

Sonderheft 2/2019

Sonderheft 1/2019

Ausgabe 1/2019

Ausgabe 4/2018

Sonderheft 4/2018

Sonderheft 3/2018

Ausgabe 3/2018

Sonderheft 2/2018

Ausgabe 2/2018